Business Context and Reporting Period
This Form 8-K Current Report was filed by Bristol-Myers Squibb Company on February 13, 2024. The report discloses a change in senior management effective February 15, 2024.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on personnel changes and does not contain financial performance data.
Material Changes
The primary material change reported is the appointment of Mr. Phil Holzer as Senior Vice President and Controller, effective February 15, 2024. Concurrently, Ms. Sharon Greenlees, the current Senior Vice President and Controller, will assume another role within the Company.
Management Commentary and Risks
Mr. Holzer, 48, has been with the Company since 2001. His recent roles include Senior Vice President, Finance, Treasury and Tax Operations (2021–2024), and Senior Vice President, Enterprise Integrations (2019–2021). He holds a Bachelor of Science in Accounting and is a Certified Public Accountant. The filing states there are no family relationships between Mr. Holzer and any director or executive officer, and no arrangements regarding his selection require disclosure under Item 404(a) of Regulation S-K.
Investor Verification Points
- Confirm the effective date of the leadership transition (February 15, 2024).
- Verify Mr. Holzer's prior tenure and specific roles within the Company's finance and operations divisions.
- Note that this filing contains no financial results or forward-looking guidance.